Psychedelic Biz Pledges No IP Suits Over Natural Mescaline
A California life sciences company attempting to patent a treatment derived from the psychedelic mescaline has made a public promise not to bring intellectual property litigation over the noncommercial or traditional...To view the full article, register now.
Already a subscriber? Click here to view full article